1. Home
  2. JANX vs HIPO Comparison

JANX vs HIPO Comparison

Compare JANX & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$10.13

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

N/A

Current Price

$35.84

Market Cap

907.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
JANX
HIPO
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
907.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
JANX
HIPO
Price
$10.13
$35.84
Analyst Decision
Buy
Buy
Analyst Count
18
5
Target Price
$33.14
★ $44.00
AVG Volume (30 Days)
★ 946.4K
241.0K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 235.37
EPS
N/A
★ 0.98
Revenue
$10,000,000.00
★ $468,600,000.00
Revenue This Year
$174.21
$25.50
Revenue Next Year
N/A
$32.25
P/E Ratio
★ N/A
$37.28
Revenue Growth
N/A
★ 25.93
52 Week Low
$10.16
$24.08
52 Week High
$35.34
$39.39

Technical Indicators

Market Signals
Indicator
JANX
HIPO
Relative Strength Index (RSI) 25.34 47.47
Support Level N/A $24.68
Resistance Level $14.47 $39.39
Average True Range (ATR) 1.16 1.34
MACD -0.48 -0.16
Stochastic Oscillator 0.33 40.61

Price Performance

Historical Comparison
JANX
HIPO

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

Share on Social Networks: